BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19664630)

  • 21. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma.
    Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS
    J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
    Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
    J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full-length genomic analysis of hepatitis B virus isolates in a patient progressing from hepatitis to hepatocellular carcinoma.
    Lin X; Qian GS; Lu PX; Wu L; Wen YM
    J Med Virol; 2001 Aug; 64(4):299-304. PubMed ID: 11468748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
    Guo X; Jin Y; Qian G; Tu H
    J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus mutations associated with in situ expression of hepatitis B core antigen, viral load and prognosis in chronic hepatitis B patients.
    Zhu R; Zhang HP; Yu H; Li H; Ling YQ; Hu XQ; Zhu HG
    Pathol Res Pract; 2008; 204(10):731-42. PubMed ID: 18597951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
    Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
    J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam.
    Truong BX; Seo Y; Yano Y; Ho PT; Phuong TM; Long DV; Son NT; Long NC; Kato H; Hayashi Y; Trach NK; Kasuga M
    Int J Mol Med; 2007 Feb; 19(2):293-9. PubMed ID: 17203204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.
    Dong Q; Chan HL; Liu Z; Chan DP; Zhang B; Chen Y; Kung HF; Sung JJ; He ML
    Biochem Biophys Res Commun; 2008 Oct; 374(4):773-6. PubMed ID: 18675784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
    Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
    J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of hepatitis B viral load on recurrence after complete necrosis in patients with hepatocellular carcinoma who receive transarterial chemolipiodolization: implications for viral suppression to reduce the risk of cancer recurrence.
    Jang JW; Choi JY; Bae SH; Yoon SK; Woo HY; Chang UI; Kim CW; Nam SW; Cho SH; Yang JM; Lee CD
    Cancer; 2007 Oct; 110(8):1760-7. PubMed ID: 17724708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H; Kumada T; Kaneoka Y; Murakami Y
    J Hepatol; 2008 Jan; 48(1):43-50. PubMed ID: 18023912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations.
    Liu CJ; Kao JH
    J Gastroenterol Hepatol; 2008 Mar; 23(3):347-50. PubMed ID: 18318819
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
    Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial analysis of hepatitis B virus DNA from hepatocellular carcinoma showing negative hepatitis B virus surface antigen: an analysis of two Japanese cases.
    Shiota G; Oyama K; Udagawa A; Nomi T; Tanaka K; Tsutsumi A; Noguchi N; Okano J; Kishimoto Y; Kanbe T; Kishimoto H; Kawasaki H
    Hepatogastroenterology; 2009; 56(94-95):1516-20. PubMed ID: 19950820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma and hepatitis B virus.
    Chan HL; Sung JJ
    Semin Liver Dis; 2006 May; 26(2):153-61. PubMed ID: 16673293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
    Kao JH; Chen PJ; Chen DS
    Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
    Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
    Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.